-
List of field safety notices (FSNs) from medical device manufacturers from 27 April to 1 May 2015.
-
List of field safety notices (FSNs) from medical device manufacturers from 20 to 24 April 2015.
-
(Allergan UK Limited) Specific batch including a Danish language pack was shipped to the UK in error. Class 3 – action within 5 days. (EL (15)A/03)
-
List of field safety notices (FSNs) from medical device manufacturers from 13 to 17 April 2015.
-
List of field safety notices (FSNs) from medical device manufacturers from 7 to 10 April 2015.
-
List of field safety notices (FSNs) from medical device manufacturers from 30 to 3 April 2015.
-
Sanofi is recalling a specific batch of syringe barrels used in batch 4LL66 of this product, distributed from 12 January 2015.
-
(Aventis Pharma Limited and Winthrop Pharmaceuticals UK Limited) The smell associated with some batches is said to be a result of the foil packaging, but patients should continue taking their medicine. (EL (15)A/02)
-
List of field safety notices (FSNs) from medical device manufacturers from 23 to 27 March 2015.
-
List of field safety notices (FSNs) from medical device manufacturers from 16 to 20 March 2015.
-
Takeda UK Ltd is recalling a specific batch of Vitaros 3mg/g cream 4 x 100mg.
-
Takeda UK Ltd is recalling specific batches of Rienso 30mg/ml solution for infusion (Ferumoxytol).
-
List of field safety notices (FSNs) from medical device manufacturers from 9 to 13 March 2015.
-
List of field safety notices (FSNs) from medical device manufacturers from 2 to 6 March 2015.
-
List of field safety notices (FSNs) from medical device manufacturers from 23 to 27 February 2015.
-
List of field safety notices (FSNs) from medical device manufacturers from 16 to 20 February 2015.
-
List of field safety notices (FSNs) from medical device manufacturers from 9 to 13 February 2015.
-
List of field safety notices (FSNs) from medical device manufacturers from 2 to 6 February 2015.
-
List of field safety notices (FSNs) from medical device manufacturers from 26 to 30 January 2015.
-
List of field safety notices (FSNs) from medical device manufacturers from 19 to 23 January 2015.
-
List of field safety notices (FSNs) from medical device manufacturers from 12 to 16 January 2015.
-
(Novartis Consumer Health UK Limited and Actavis Group PTC EHF): Product reclassified from P to POM due to safety concerns – class 2 action within 48 hours (EL (15)A/01)
-
(Lundbeck Limited) May result in suboptimal dosage of the product - class 2 action within 48 hours. (EL (14)A/19)
-
(GlaxoSmithKline) Check each vial for cracks by turning upside down and looking for chips, cracks or damage where base meets side wall. (EL (14)A/15)
-
(Boston Scientific) Rapid battery depletion leads to risk of loss of therapy. (MDA/2014/039)
-
(All manufacturers) Delays in acting on field safety notices can compromise patient safety (FSNs). (MDA/2014/037)
-
(St Jude Medical) These defibrillators can delay or reduce the therapy that can be delivered by the ICD.(MDA/2014/035)
-
(McNeil Products Limited) Remaining stocks of the above products should be quarantined - class 2 action within 48 hours. (EL (14)A/14)
-
(Teva UK Limited) red precipitate found during stability testing under cold storage conditions - class 2 action within 48 hours. (EL (14)A/13)
-
(ViroPharma SPRL) Pharmacists should quarantine batches and return them to original wholesaler for credit - class 2 action within 48 hours. (EL (14)A/12)
-
(Wockhardt UK Ltd) Remaining stock from affected batches should be quarantined and returned to the original supplier for credit - class 2 action within 48 hours. (EL (14)A/11)
-
(Penn Pharma, distributed in Quantum Pharmaceutical livery) May result in evaporation of aqueous component of product and increase in concentration of Midazolam. (EL (14)/A10)
-
(All types, makes and models) Report cases in women who have breast implants or who have had them removed. (MDA/2014/027)
-
(Wockhardt UK Ltd) Should not be used in neonates and infants under 1 year old until further notice. (EL (14)A/09)
-
(Reckitt Benckiser Healthcare (UK) Limited) Remaining stock of batches should be quarantined and returned to original supplier for credit. - class 2 action within 48 hours. (EL (14)A/08)
-
(Mylan on behalf of Strides Arcolab International Limited) Remaining stocks of affected batches should be quarantined - class 2 action within 48 hours. (EL (14)A/07)
-
(ITH Pharma Ltd) Remaining stocks should be quarantined and returned to original supplier for credit - class 2 action within 48 hours. (EL (14)A/06)
-
(ITH Pharma Ltd) Small number of reported cases of bacillus cereus septicaemia affecting neonates - class 1 action now. (EL (14)A/05)
-
(Various manufacturers) Risk if alarms are ignored or damaged breathing systems are used. (MDA/2014/020)
-
(Medtronic) Risk due to incorrect selection and delivery of bolus amount. (MDA/2014/019)
-
(Waldemar Link GmbH & Company.KG) Consider annual review of patients for up to 5 years after implantation, including X-rays to detect progression of bearing wear. (MDA/2014/018)
-
(Pace Medical Inc) CE-marking suspended due to quality system failings. (MDA/2014/015)
-
(Reckitt Benckiser Healthcare (UK) Limited) Remaining stock should be quarantined and returned to original supplier for credit - class 2 action within 48 hours. (EL (14)A/04)
-
(Roche Diagnostics Ltd) Increased risk that the vibration alarm will not work as a result of a changed component. (MDA/2014/008)
-
(Gilead Sciences Limited) Pharmacists should quarantine any remaining stocks affected batches and return them to the original wholesaler for credi - class 2 action within 48 hours. (EL (14)A/03)
-
(Carestream Health) Risk of injury if joint between scissor arm and bracket fails. (MDA/2014/005)
-
(Merck Sharp and Dohme) Increase in the number of adverse events and product complaints following introduction of ‘winged’ presentation - class 2 action within 48 hours. (EL (14)A/02)
-
(All products) Could fail during use with a risk of injury to patient and user. (MDA/2014/004)
-
(Teva UK Ltd) Leaflet incorrectly states take 1 or 2 tablets a day. (EL (14)A/01)
-
(Accord Healthcare Limited) Recipients should quarantine any remaining stock and return it to supplier for credit - class 2 action within 48 hours. (EL (13)A/32)